These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 16896038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
    Carmella SG, Ming X, Olvera N, Brookmeyer C, Yoder A, Hecht SS.
    Chem Res Toxicol; 2013 Aug 19; 26(8):1209-17. PubMed ID: 23837805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.
    Byrd GD, Ogden MW.
    J Mass Spectrom; 2003 Jan 19; 38(1):98-107. PubMed ID: 12526011
    [Abstract] [Full Text] [Related]

  • 8. r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation.
    Hecht SS, Chen M, Yagi H, Jerina DM, Carmella SG.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 19; 12(12):1501-8. PubMed ID: 14693744
    [Abstract] [Full Text] [Related]

  • 9. Development, validation and transfer of a hydrophilic interaction liquid chromatography/tandem mass spectrometric method for the analysis of the tobacco-specific nitrosamine metabolite NNAL in human plasma at low picogram per milliliter concentrations.
    Pan J, Song Q, Shi H, King M, Junga H, Zhou S, Naidong W.
    Rapid Commun Mass Spectrom; 2004 Dec 19; 18(21):2549-57. PubMed ID: 15468159
    [Abstract] [Full Text] [Related]

  • 10. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
    Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 19; 18(1):260-6. PubMed ID: 19124507
    [Abstract] [Full Text] [Related]

  • 11. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H, Zhang X, Tian Y, Tang G, Liu Y, Hu Q.
    J Pharm Biomed Anal; 2012 Apr 07; 63():17-22. PubMed ID: 22366322
    [Abstract] [Full Text] [Related]

  • 12. Development, validation, and application of a liquid chromatography-tandem mass spectrometry method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human hair.
    Yao L, Yang J, Guan YF, Liu BZ, Zheng SJ, Wang WM, Zhu XL, Zhang ZD.
    Anal Bioanal Chem; 2012 Nov 07; 404(8):2259-66. PubMed ID: 22926132
    [Abstract] [Full Text] [Related]

  • 13. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W, Ferguson SG, Nichols DS, Patel R, Jacobson GA.
    J Pharm Biomed Anal; 2016 Nov 30; 131():327-332. PubMed ID: 27632782
    [Abstract] [Full Text] [Related]

  • 14. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG, Ye M, Upadhyaya P, Hecht SS.
    Cancer Res; 1999 Aug 01; 59(15):3602-5. PubMed ID: 10446969
    [Abstract] [Full Text] [Related]

  • 15. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry.
    Yao L, Zheng S, Guan Y, Yang J, Liu B, Wang W, Zhu X.
    Anal Chim Acta; 2013 Jul 25; 788():61-7. PubMed ID: 23845482
    [Abstract] [Full Text] [Related]

  • 16. [Detection of metabolites of tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung cancer smokers' urine].
    Zhang T, Lai B, Duan L, Wang X.
    Zhongguo Fei Ai Za Zhi; 2006 Jun 20; 9(3):231-5. PubMed ID: 21172151
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry.
    Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, Bernert JT.
    Anal Chem; 2005 Dec 01; 77(23):7639-45. PubMed ID: 16316171
    [Abstract] [Full Text] [Related]

  • 18. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG, Akerkar SA, Richie JP, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep 01; 4(6):635-42. PubMed ID: 8547830
    [Abstract] [Full Text] [Related]

  • 19. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism.
    Hecht SS, Hatsukami DK, Bonilla LE, Hochalter JB.
    Chem Res Toxicol; 1999 Feb 01; 12(2):172-9. PubMed ID: 10027795
    [Abstract] [Full Text] [Related]

  • 20. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke.
    Parsons WD, Carmella SG, Akerkar S, Bonilla LE, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1998 Mar 01; 7(3):257-60. PubMed ID: 9521443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.